Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.
about
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Preclinical Evaluation of Sequ ...... creatic Ductal Adenocarcinoma.
@en
type
label
Preclinical Evaluation of Sequ ...... creatic Ductal Adenocarcinoma.
@en
prefLabel
Preclinical Evaluation of Sequ ...... creatic Ductal Adenocarcinoma.
@en
P2093
P2860
P1476
Preclinical Evaluation of Sequ ...... creatic Ductal Adenocarcinoma.
@en
P2093
Bingbing Dai
David Roife
Frederick F Lang
Jason B Fleming
Juan Fueyo-Margareto
Mayrim V Rios Perez
Michael Pratt
Rolf A Brekken
P2860
P304
P356
10.1158/1535-7163.MCT-16-0526
P577
2017-01-30T00:00:00Z